Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nephro Care IndiaNSE:NEPHROCARE +2.29%48 Net Margin % is 4.84% as of Mar. 2026, which is 24% below its 10-year median of 6.39. GuruFocus rates NSE:NEPHROCARE with a GF Score™ of 48/100. The stock has 2 warning signs investors should review. Among 672 Healthcare Providers & Services companies, Nephro Care India ranks better than 53.42% on this metric.
The historical rank and industry rank for Nephro Care India's Net Margin % or its related term are showing as below:
NSE:NEPHROCARE'
s Net Margin % Range Over the Past 10 Years
Min: -0.29 Med: 6.39 Max: 16.2
Current: 3.28
NSE:NEPHROCARE's Net Margin % is ranked better than 53.42% of 672
companies
in the Healthcare Providers & Services industry
Industry Median: 2.83
vs NSE:NEPHROCARE: 3.28
Nephro Care India (NSE:NEPHROCARE) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nephro Care India Net Margin % Related Terms
Nephro Care India Net Margin % Historical Data
* Premium members only.
The historical data trend for Nephro Care India's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:NEPHROCARE vs HCA, THC, EHC: Net Margin % Comparison
For the Medical Care Facilities subindustry, Nephro Care India's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nephro Care India Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nephro Care India's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nephro Care India's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nephro Care India (NSE:NEPHROCARE) has a Net Margin % of 4.84% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nephro Care India and its competitors. This is 24% below median its historical median of 6.39. According to the industry distribution chart, Nephro Care India ranks #313 out of 672 companies in the Healthcare Providers & Services industry, placing it in the top 46.6%.
Is Nephro Care India's Net Margin % too high?
Nephro Care India's current Net Margin % of 4.84% is 24% below median its 10-year median of 6.39. The Healthcare Providers & Services industry median Net Margin % is 2.83. Nephro Care India's value of 4.84% is 71% above this industry median. Based on the distribution chart, Nephro Care India ranks #313 out of 672 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Nephro Care India has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Nephro Care India's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nephro Care India ranks #313 out of 672 companies for Net Margin %. This puts Nephro Care India in the upper half of its industry. The industry median Net Margin % is 2.83. Nephro Care India's value of 4.84% is 71% above this benchmark. While the company's 10-year median is 6.39 vs. the industry median of 2.83, Nephro Care India has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.83, based on 672 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nephro Care India's current Net Margin % of 4.84% is 71% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nephro Care India and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nephro Care India's current Net Margin % is 4.84%, which is 24% below median its own 10-year median of 6.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nephro Care India stock overvalued right now?
Nephro Care India (NSE:NEPHROCARE) has a current Net Margin % of 4.84%. The current Net Margin % is 4.84%, which is 24% below median its 10-year median of 6.39 and 71% above the Healthcare Providers & Services industry median of 2.83. Nephro Care India's overall GF Score™ is 48/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nephro Care India (NSE:NEPHROCARE), the current Net Margin % is 4.84% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Nephro Care India Ltd is a Kolkata-based healthcare provider specializing in comprehensive medical services for renal patients. The company serves as a one-stop treatment center, offering a broad spectrum of clinical and lifestyle solutions, along with specialized treatments for renal insufficiency. Its holistic care framework addresses not only the medical and physiological aspects of treatment but also focuses on lifestyle and spiritual wellness, providing an integrated approach to patient care.
48GF Score
Get the complete analysis for NSE:NEPHROCARE
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:NEPHROCARE has been successfully added to your 
